Structure of the fibrinogen γ-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization

Protein Science

Volumn 8, Issue 12, 1999, Pages 2663-2671

  Ware, Scott ^a   Donahue, John P ^b   Hawiger, Jacek ^b   Anderson, Wayne F ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Crystal structure; Crystallization; Fibrinogen; Fusion protein; Glutathione S transferase; Integrin

Indexed keywords

BLOOD CLOTTING FACTOR 13A; CARRIER PROTEIN; FIBRINOGEN; FIBRINOGEN RECEPTOR; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN;

ARTICLE; BINDING SITE; BLOOD CLOTTING; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTALLIZATION; ESCHERICHIA COLI; HUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; THROMBOCYTE; WESTERN BLOTTING; X RAY DIFFRACTION;

ESCHERICHIA COLI;

EID: 0033458848     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.12.2663     Document Type: Article

References (38)

1. Bacon DJ, Anderson WF. 1988. A fast algorithm for rendering space-filling molecule pictures. J Mol Graphics 6:219-220.
2. Bernstein FC, Koetzle TF, Williams GJB, Meyer EF Jr, Brice MD, Rodgers JR, Kennard O, Shimanouchi T, Tasumi M. 1977. The Protein Data Bank: A computer-based archival file for macromolecular structures. J Mol Biol 112:535-542.
3. Blumenstein M, Matsueda GR, Timmons S, Hawiger J. 1992. A beta-turn is present in the 392-411 segment of the human fibrinogen gamma-chain. Effects of structural changes in this segment on affinity to antibody 4A5. Biochemistry 31:10692-10698.
4. Brünger AT. 1992a. Free R value: A novel statistical quantity for assessing the accuracy of crystal structures. Nature 355:472-475.
5. Brünger AT. 1992b. X-PLOR version 3.1: A system for X-ray crystallography and NMR. New Haven: Yale University Press.
6. Brünger AT, Krukowski A, Erickson J. 1990. Slow-cooling protocols for crystallographic refinement by simulated annealing. Acta Crystallogr A46:585-593.
7. Brünger AT, Kuriyan J, Karplus M. 1987. Crystallographic R factor refinement by molecular dynamics. Science 235:458-460.
8. Chen R, Doolittle RF. 1971. Cross-linking sites in human and bovine fibrin. Biochemistry 10:4487-4491.
9. Chung DW, Chan WY, Davie EW. 1983. Characterization of a complementary deoxyribonucleic acid coding for the gamma chain of human fibrinogen. Biochemistry 22:3250-3256.
10. Donahue JP, Patel H, Anderson WF, Hawiger J. 1994. Three-dimensional structure of the platelet integrin recognition domain of the fibrinogen γ-chain obtained by carrier protein driven crystallization. Proc Natl Acad Sci USA 91:12178-12182.
11. Doolittle RF. 1973. Structural aspects of the fibrinogen to fibrin conversion. Adv Prot Chem 27:1-109.
12. Doolittle RF, Everse SJ, Spraggon G. 1996. Human fibrinogen: Anticipating a 3-dimensional structure. FASEB J 10:1464-1470.
13. Farrell DH, Thiagarajan P, Chung DW, Davie EW. 1992. Role of fibrinogen alpha and gamma chain sites in platelet aggregation. Proc Natl Acad Sci USA 89:10729-10732.
14. Hawiger J. 1995. Adhesive ends of fibrinogen and its antiadhesive peptides: The end of a saga? Semin Hematol 32:99-109.
15. Hodel A, Kim S-H, Brünger AT. 1992. Model bias in macromolecular crystal structures. Acta Crystallogr A48:851-858.
16. Jiang J-S, Brünger AT. 1994. Protein hydration observed by X-ray diffraction: Solvation properties of penicillopepsin and neuraminidase crystal structures. J Mol Biol 243:100-115.
17. Jones TA, Kjeldgaard M. 1995. O - The manual (version 5.10). Uppsala: Uppsala University. pp 1-172.
18. Kleywegt GJ, Brünger AT. 1996. Checking your imagination: Application of the free R value. Structure 4:897-904.
19. Kloczewiak M, Timmons S, Bednarek MA, Sakon M, Hawiger J. 1989. Platelet receptor recognition domain on the gamma chain of human fibrinogen and its synthetic peptide analogues. Biochemistry 28:2915-2919.
20. Kloczewiak M, Timmons S, Lukas TJ, Hawiger J. 1984. Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain. Biochemistry 23:1767-1774.
21. Lim K, Ho JX, Keeling K, Gilliland GL, Ji X, Ruker F, Carter DC. 1994. Three-dimensional structure of Schistosoma japonicum glutathione S-transferase fused with a six-amino acid conserved neutralizing epitope of gp41 from HIV. Protein Sci 3:2233-2244.
22. Mayo KH, Fan F, Beavers MP, Eckardt A, Keane P, Hoekstra WJ, Andrade-Gordon P. 1996. Integrin receptor GPIIb/IIIa bound state conformation of the fibrinogen γ-chain C-terminal peptide 400-411: NMR and transfer NOE studies. Biochemistry 35:4434-4444.
23. McTigue MA, Williams DR, Tainer JA. 1995. Crystal structures of a schistosomal drug and vaccine target: Glutathione S-transferase from Schistosoma japonica and its complex with the leading antischistosomal drug praziquantel. J Mol Biol 246:21-27.
24. Merritt EA, Murphy MEP. 1994. Raster3D version 2.0 - A program for photo-realistic molecular graphics. Acta Crystallogr D50:869-873.
25. Navaza J. 1994. AMoRe: An automated package for molecular replacement. Acta Crystallogr A50:157-163.
26. Nicholls A, Bharadwaj R, Honig B. 1993. Grasp: Graphical representation and analysis of surface properties. Biophys J 64:A166.
27. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326.
28. Peerschke EIB, Francis CW, Marder VJ. 1986. Fibrinogen binding to human platelets: Effect of gamma chain carboxyterminal structure and length. Blood 67:385-390.
29. Phillips DR, Fitzgerald L, Parise L, Steiner B. 1992. Platelet membrane glycoprotein IIb-IIIa complex: Purification, characterization and reconstitution into phospholipid vesicles. Methods Enzymol 215:244-263.
30. Purves L, Purves M, Brandt W. 1987. Cleavage of fibrin-derived D-dimer into monomers by endopeptidase from puff adder venom (Bitis arietans) acting at cross-linked sites of the γ-chain. Biochemistry 26:4640-4646.
31. Read RJ. 1986. Improved fourier coefficients for maps using phases from partial structures with errors. Acta Crystallogr A52:140-149.
32. Rice LM, Brünger AT. 1994. Torsion angle dynamics: Reduced variable conformational sampling enhances crystallographic structure refinement. Proteins 19:277-290.
33. Rossjohn J, McKinstry WJ, Oakley AJ, Verger D, Flanagan J, Chelvanayagam G, Tan KL, Board PG, Parker MW. 1998. Human theta class glutathione transferase: The crystal structure reveals a sulfate-binding pocket within a buried active site. Structure 6:309-322.
34. Rossmann MG. 1990. The molecular replacement method. Acta Crystallogr A46:73-82.
35. Smith DB, Johnson KS. 1988. Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene 67:31-40.
36. Spraggon G, Everse SJ, Doolittle RF. 1997. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin. Nature 389:455-450.
37. Strong DD, Laudano AP, Hawiger J, Doolittle RF. 1982. Isolation, characterization and synthesis of peptides from human fibrinogen that block the staphylococcal clumping reaction and construction of a synthetic clumping particle. Biochemistry 21:1414-1420.
38. Yee VC, Pratt KP, Cote HC, Trong IL, Chung DW, Davie EW, Stenkamp RE, Teller DC. 1997. Crystal structure of a 30 kDa C-terminal fragment from the γ-chain of human fibrinogen. Structure 5:125-120.